Company Filing History:
Years Active: 1997-1999
Title: Fairooz F Kabbinavar: Innovator in Platelet Derived Growth Factor Research
Introduction
Fairooz F Kabbinavar is a notable inventor based in Woodland Hills, California. He has made significant contributions to the field of medical research, particularly in the treatment of disorders related to platelet derived growth factor (PDGF). With a total of two patents to his name, his work focuses on innovative compounds that can inhibit PDGF receptor activity.
Latest Patents
Kabbinavar's latest patents revolve around the development of compounds that inhibit PDGF receptor activity. These compounds are designed to selectively target members of the PDGF receptor super family, which includes PDGF-R and related kinases such as Flt and KDR. The featured compounds have shown effectiveness in cell cultures, reducing the activity of PDGF-R and related kinases. One notable compound, A10, has demonstrated the ability to inhibit the growth of tumor cells in vivo. This research aims to provide treatment options for patients suffering from cell proliferative disorders characterized by inappropriate PDGF-R activity.
Career Highlights
Throughout his career, Fairooz F Kabbinavar has worked with esteemed organizations, including Sugen Incorporated and the University of California. His experience in these institutions has contributed to his expertise in the field of medical research and innovation.
Collaborations
Kabbinavar has collaborated with notable colleagues such as Klaus Peter Hirth and Donna Pruess Schwartz. These partnerships have likely enhanced his research and development efforts in the area of platelet derived growth factor.
Conclusion
Fairooz F Kabbinavar is a distinguished inventor whose work in platelet derived growth factor research has the potential to impact the treatment of various disorders. His innovative compounds and collaborations reflect his commitment to advancing medical science.